Abstract
Patients with permanent disability, patients with chronic diseases such as obstructive lung disease, and the terminal patients all have in common the fact that their medical condition cannot usually be reversed. Such patients often engender a feeling of helplessness in the physician. Demoralization is characterized by hopelessness, loss of meaning, and existential distress. It is associated with chronic medical illness, disability, bodily disfigurement, fear of loss of dignity, social isolation, feelings of dependency on others, and the fear of being a burden. Psychiatric issues and their management associated with chronic lung disease and cance as well as with the dying patient, palliative care, and care of the care-givers are discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Albinsson, L., Strang, P., 2003. Differences in supporting families of dementia patients and cancer patients: a palliative perspective. Palliat Med 17, 359–367.
Andrade, C. (2012). Breast cancer and antidepressant use. Journal of Clinical Psychiatry, 73, e1156–e1157.
Applebaum, A. J., & Breitbart, W. (2012). Care for the cancer caregiver: A systematic review. Palliative & Supportive Care, 1–22, 231–252.
Artherholt, S. B., & Fann, J. R. (2011). Psychosocial care in cancer. Current Psychiatry Reports, 14, 23–29.
Braam, K. I., van der Torre, P., Takken, T., Veening, M. A., van Dulmen-den Broeder, E., & Kaspers, G. J. (2013). Physical exercise training interventions for children and young adults during and after treatment for childhood cancer. Cochrane Database of Systematic Reviews, 4, CD008796.
Boesen, E.H., Johansen, C., 2008. Impact of psychotherapy on cancer survival: time to move on? Current opinion in oncology 20, 372–377.
Breitbart, W., & Alici, Y. (2010). Psychostimulants for cancer-related fatigue. Journal of the National Comprehensive Cancer Network, 8, 933–942.
Breitbart, W., & Alici-Evcimen, Y. (2007). Update on psychotropic medications for cancer-related fatigue. Journal of the National Comprehensive Cancer Network, 5, 1081–1091.
Brintzenhofe-Szoc, K. M., Levin, T. T., Li, Y., Kissane, D. W., & Zabora, J. R. (2009). Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics, 50, 383–391.
Brown, E.S., Gan, V., Jeffress, J., Wood, B.L., Miller, B.D., Khan, D.A., 2008. Antidepressant treatment of caregivers of children with asthma. Psychosomatics 49, 420–425.
Brown, R. W., Maple, A. M., Perna, M. K., Sheppard, A. B., Cope, Z. A., & Kostrzewa, R. M. (2012). Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model. Developmental Neuroscience, 34, 140–151.
Brown, E. S., Vornik, L. A., Khan, D. A., & Rush, A. J. (2007). Bupropion in the treatment of outpatients with asthma and major depressive disorder. International Journal of Psychiatry in Medicine, 37, 23–28.
Carney, C. P., Jones, L., & Woolson, R. F. (2006). Medical comorbidity in women and men with schizophrenia: A population-based controlled study. Journal of General Internal Medicine, 21, 1133–1137.
Carson, H. J., Zweigart, M., & Lueck, N. E. (2000). Death from asthma associated with sertraline overdose. The American Journal of Forensic Medicine and Pathology, 21, 273–275.
Chee, Y. C., & Poh, S. C. (1983). Myoclonus following severe asthma: Clonazepam relieves. Australian and New Zealand Journal of Medicine, 13, 285–286.
Chow, E., Tsao, M. N., & Harth, T. (2004). Does psychosocial intervention improve survival in cancer? A meta-analysis. Palliative Medicine, 18(1), 25–31.
Clarke, D. M., & Kissane, D. W. (2002). Demoralization: its phenomenology and importance. The Australian and New Zealand Journal of Psychiatry, 36, 733–742.
Clarke, D. M., Kissane, D. W., Trauer, T., & Smith, G. C. (2005). Demoralization, anhedonia and grief in patients with severe physical illness. World Psychiatry, 4, 96–105.
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998). Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. The American Journal of Psychiatry, 155, 1490–1501.
Daniels, J., Kissane, D.W., 2008. Psychosocial interventions for cancer patients. Current opinion in oncology 20, 367–371.
DeVane, C. L., Hill, M., & Antal, E. J. (1998). Therapeutic drug monitoring of alprazolam in adolescents with asthma. Therapeutic Drug Monitoring, 20, 257–260.
Dunn, A. J., Wang, J., & Ando, T. (1999). Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Advances in Experimental Medicine and Biology, 461, 117–127.
Epel, E. S., Blackburn, E. H., & Lin, J. (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences of the United States of America, 101, 17312–17315.
Fontaine, R., Chouinard, G., & Annable, L. (1984). Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. The American Journal of Psychiatry, 141, 848–852.
Frank, J. D. (1961). Persuasion and healing: A comparative study of psychotherapy. Baltimore: Johns Hopkins Press.
Frank, J. D., & Frank, J. (1991). Persuasion and healing: A comparative study of psychotherapy (3rd ed.). Baltimore: Johns Hopkins University Press.
Frick, L. R., & Rapanelli, M. (2013). Antidepressants: Influence on cancer and immunity? Life Sciences, 92, 525–532.
Goodwin, R. D., Jacobi, F., & Thefeld, W. (2003). Mental disorders and asthma in the community. Archives of General Psychiatry, 60, 1125–1130.
Goodwin, P. J., Leszcz, M., & Ennis, M. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. The New England Journal of Medicine, 345(24), 1719–1726.
Goodwin, R. D., & Marusic, A. (2004). Asthma and suicidal ideation among youth in the community. Crisis, 25, 99–102.
Guell, R., Resqueti, V., Sangenis, M., Morante, F., Martorell, B., Casan, P., et al. (2006). Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest, 129, 899–904.
Howard, C., Hallas, C. N., Wray, J., & Carby, M. (2009). The relationship between illness perceptions and panic in chronic obstructive pulmonary disease. Behaviour Research and Therapy, 47, 71–76.
Humeniuk, E., Wegrzyn-Szkutnik, I., Milanowski, J., & Klimkowski, M. (2003). Psychosocial problems of patients with bronchial asthma. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 58, 187–194.
Humphry, D. (2002). Final exit: the practicalities of self-deliverance and assisted suicide for the dying. New York: Dell.
Hynninen, M. J., Bjerke, N., Pallesen, S., Bakke, P. S., & Nordhus, I. H. (2010). A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respiratory Medicine, 104, 986–994.
Iamandescu, I. B., & Mihailescu, A. (2008). Bronchial asthma with psychogenic trigger. Romanian Journal of Internal Medicine, 46, 113–118.
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013). Sleep disturbance, inflammation and depression risk in cancer survivors. Brain, Behavior, and Immunity, 30(Suppl), S58–S67.
Jacobsen, J. C., Maytal, G., & Stern, T. A. (2007). Demoralization in medical practice. Prim Care Companion to the Journal of Clinical Psychiatry, 9, 139–143.
Jain, A., & Lolak, S. (2009). Psychiatric aspects of chronic lung disease. Current Psychiatry Reports, 11, 219–225.
Joachim, R. A., Quarcoo, D., Arck, P. C., Herz, U., Renz, H., & Klapp, B. F. (2003). Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosomatic Medicine, 65, 811–815.
Joly, F., Rigal, O., Noal, S., & Giffard, B. (2011). Cognitive dysfunction and cancer: which consequences in terms of disease management? Psychooncology, 20, 1251–1258.
Kast, R. E., & Foley, K. F. (2007). Cancer chemotherapy and cachexia: Mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. European Journal of Cancer Care, 16, 351–354.
Kayahan, B., Karapolat, H., Atyntoprak, E., Atasever, A., & Ozturk, O. (2006). Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respiratory Medicine, 100, 1050–1057.
Kelly, W. D., & Friesen, S. R. (1950). Do cancer patients want to be told? Surgery, 27, 822–826.
Kim, S. H., Han, D. H., Joo, S. Y., & Min, K. J. (2010). The effect of dopamine partial agonists on the nicotine dependency in patients with schizophrenia. Human Psychopharmacology, 25, 187–190.
Kissane, D., 2009. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology 18, 1–5.
Kissane, D. W., Clarke, D. M., & Street, A. F. (2001). Demoralization syndrome–A relevant psychiatric diagnosis for palliative care. Journal of Palliative Care, 17, 12–21.
Krommydas, G., Gourgoulianis, K. I., Karamitsos, K., Krapis, K., Kotrotsiou, E., & Molyvdas, P. A. (2005). Therapeutic value of antidepressants in asthma. Medical Hypotheses, 64, 938–940.
Kubler-Ross, E. (1969). On death and dying. New York: Simon & Schuster/Touchstone.
Lehrer, P. M., Isenberg, S., & Hochron, S. M. (1993). Asthma and emotion: A review. Journal of Asthma, 30, 5–21.
Leigh, H. (1974). Psychotherapy of a suicidal, terminal cancer patient. International Journal of Psychiatry in Medicine, 5(2), 173–182.
Ley, R. (1989). Dyspneic-fear and catastrophic cognitions in hyperventilatory panic attacks. Behaviour Research and Therapy, 27, 549–554.
Lo, C., Zimmermann, C., Rydall, A., Walsh, A., Jones, J. M., Moore, M. J., et al. (2010). Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. Journal of Clinical Oncology, 28, 3084–3089.
Mancuso, C. A., Peterson, M. G., & Charlson, M. E. (2000). Effects of depressive symptoms on health-related quality of life in asthma patients. Journal of General Internal Medicine, 15, 301–310.
Masoli, M., Fabian, D., Holt, S., & Beasley, R. (2004). The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy, 59, 469–478.
Mathias, C., Cardeal Mendes, C. M., Ponde de Sena, E., Dias de Moraes, E., Bastos, C., Braghiroli, M. I., et al. (2006). An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer. Annals of Oncology, 17, 1792–1796.
Matsuoka, H., Makimura, C., Koyama, A., Otsuka, M., Okamoto, W., Fujisaka, Y., et al. (2012). Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin. Anticancer Research, 32, 1805–1809.
Mazzotti, E., Sebastiani, C., Antonini Cappellini, G.C., Marchetti, P., 2012. Predictors of mood disorders in cancer patients’ caregivers. Support Care Cancer 21, 643–647.
McClellan, R., 2013. Exercise programs for patients with cancer improve physical functioning and quality of life. J Physiother 59, 57.
Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004). Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nordic Journal of Psychiatry, 58, 65–70.
Minton, O., Richardson, A., Sharpe, M., Hotopf, M., & Stone, P. C. (2011). Psychostimulants for the management of cancer-related fatigue: A systematic review and meta-analysis. Journal of Pain and Symptom Management, 41, 761–767.
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., et al. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology, 12, 160–174.
Miyashita, M., Misawa, T., Abe, M., Nakayama, Y., Abe, K., Kawa, M., 2008. Quality of life, day hospice needs, and satisfaction of community-dwelling patients with advanced cancer and their caregivers in Japan. J Palliat Med 11, 1203–1207.
Moss, E. L., Simpson, J. S., Pelletier, G., & Forsyth, P. (2006). An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology, 15, 259–267.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. The New England Journal of Medicine, 344, 961–966.
Noone, I., Crowe, M., Pillay, I., et al. (2000). Telling the truth about cancer: Views of elderly patients and their relatives. Irish Medical Journal, 93, 104–105.
Norwood, R. (2006). Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Current Opinion in Pulmonary Medicine, 12, 113–117.
Payne, M., 2006. Social objectives in cancer care: the example of palliative day care. Eur J Cancer Care (Engl) 15, 440–447.
Punekar, R. S., Short, P. F., & Moran, J. R. (2011). Use of psychotropic medications by US cancer survivors. Psycho-oncology, 21, 1237–1243.
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 176, 532–555.
Raison, C. L., & Miller, A. H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry, 54, 283–294.
Ramaswamy, S., & Bhatia, S. C. (2006). Aripiprazole therapy for nicotine dependence. Primary Care Companion to the Journal of Clinical Psychiatry, 8, 47–49.
Rayner, L., Price, A., Hotopf, M., & Higginson, I. J. (2011). The development of evidence-based European guidelines on the management of depression in palliative cancer care. European Journal of Cancer, 47, 702–712.
Richardson, J., Smith, J. E., McCall, G., Richardson, A., Pilkington, K., & Kirsch, I. (2007). Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. European Journal of Cancer Care, 16, 402–412.
Ryan, P.J., Howell, V., Jones, J., Hardy, E.J., 2008. Lung cancer, caring for the caregivers. A qualitative study of providing pro-active social support targeted to the carers of patients with lung cancer. Palliat Med 22, 233–238.
Sartor, C. E., Xian, H., Scherrer, J. F., Lynskey, M. T., Duncan, A. E., Haber, J. R., et al. (2008). Psychiatric and familial predictors of transition times between smoking stages: results from an offspring-of-twins study. Addictive Behaviors, 33, 235–251.
Seo, M., Tamura, K., & Shijo, H. (2000). Telling the diagnosis to cancer patients in Japan: Attitude and perception of patients, physicians and nurses. Palliative Medicine, 14, 105–110.
Shanmugam, G., Bhutani, S., Khan, D. A., & Brown, E. S. (2007). Psychiatric considerations in pulmonary disease. The Psychiatric Clinics of North America, 30, 761–780.
Spiegel, D., 2002. Effects of psychotherapy on cancer survival. Nature reviews. Cancer 2, 383–389.
Tang, S.T., Cheng, C.C., Lee, K.C., Chen, C.H., Liu, L.N., 2012. Mediating Effects of Sense of Coherence on Family Caregivers’ Depressive Distress While Caring for Terminally Ill Cancer Patients. Cancer Nurs.
Torta, R., Leombruni, P., Borio, R., & Castelli, L. (2011). Duloxetine for the treatment of mood disorder in cancer patients: A 12-week case–control clinical trial. Human Psychopharmacology, 26, 291–299.
Urrutia, I., Aguirre, U., Pascual, S., Esteban, C., Ballaz, A., Arrizubieta, I., et al. (2012). Impact of anxiety and depression on disease control and quality of life in asthma patients. Journal of Asthma, 49, 201–208.
Wade, S., Weil, C., Holden, G., Mitchell, H., Evans, R., 3rd, Kruszon-Moran, D., Bauman, L., Crain, E., Eggleston, P., Kattan, M., Kercsmar, C., Leickly, F., Malveaux, F., Wedner, H.J., 1997. Psychosocial characteristics of inner-city children with asthma: a description of the NCICAS psychosocial protocol. National Cooperative Inner-City Asthma Study. Pediatr Pulmonol 24, 263–276.
Walker, J., Holm Hansen, C., Martin, P., Sawhney, A., Thekkumpurath, P., Beale, C., et al. (2012). Prevalence of depression in adults with cancer: A systematic review. Annals of Oncology, 24, 895–900.
Walker, J., Sawhney, A., Hansen, C. H., Symeonides, S., Martin, P., Murray, G., et al. (2013). Treatment of depression in people with lung cancer: A systematic review. Lung Cancer, 79, 46–53.
Weil, C. M., Wade, S. L., Bauman, L. J., Lynn, H., Mitchell, H., & Lavigne, J. (1999). The relationship between psychosocial factors and asthma morbidity in inner-city children with asthma. Pediatrics, 104, 1274–1280.
Yang, Y. H., Lin, J. K., Chen, W. S., Lin, T. C., Yang, S. H., Jiang, J. K., et al. (2012). Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: An open-label pilot study. Support Care Cancer, 20, 1491–1497.
Zielinski, T. A., Brown, E. S., Nejtek, V. A., Khan, D. A., Moore, J. J., & Rush, A. J. (2000). Depression in asthma: Prevalence and clinical implications. Primary Care Companion to the Journal of Clinical Psychiatry, 2, 153–158.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Hoyle Leigh & Jon Streltzer
About this chapter
Cite this chapter
Leigh, H. (2015). Chronic Conditions, Lung Disease, Cancer, the Palliative Care Settings, and the Dying Patient. In: Leigh, H., Streltzer, J. (eds) Handbook of Consultation-Liaison Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-11005-9_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-11005-9_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11004-2
Online ISBN: 978-3-319-11005-9
eBook Packages: MedicineMedicine (R0)